-
Intravesical p21 mRNA–LNP Therapy for Bladder Cancer
2026-08-24
A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21 expression, restrained tumor growth in an orthotopic mouse model, and limited systemic exposure, supporting localized mRNA delivery as a tumor suppressor replacement strategy.
-
Quercetin, Hippo Signaling, and Cataract Protection
2026-08-24
The reference study links quercetin-mediated protection of cataractous lenses to suppression of Hippo pathway activity, improved antioxidant status, and preservation of lens epithelial-cell viability. Its combined network-pharmacology, animal, and cell-based design provides a useful framework for distinguishing pathway-associated effects from causal protection, while also suggesting carefully bounded follow-up studies involving Rho/ROCK signaling.
-
PDK4-IN-1 Hydrochloride: From Target to Flux
2026-08-23
PDK4-IN-1 hydrochloride is a selective pyruvate dehydrogenase kinase 4 inhibitor for connecting target engagement with measurable metabolic flux. This guide explains how to design interpretable PDH activation, mitochondrial metabolism, and disease-model studies while distinguishing catalog properties from lead-compound evidence.
-
Berbamine Hydrochloride in Ferroptosis Assays
2026-08-22
Berbamine hydrochloride offers a useful pathway-probing tool for connecting NF-κB activity inhibition, STAT3 modulation, and ferroptosis-oriented cancer research. This article translates the METTL16-SENP3-LTF findings in hepatocellular carcinoma into rigorous assay-design decisions while distinguishing established evidence from testable hypotheses.
-
Mapping PZP–GRP78 Signaling with Sulfo-NHS-Biotin
2026-08-22
A translational framework for using Sulfo-NHS-Biotin to interrogate cell-surface GRP78, validate PZP signaling, and strengthen mechanistic studies of intermittent-fasting-induced thermogenesis.
-
BPN-19186: Nrf2 Assay Workflows
2026-08-21
BPN-19186 provides a practical chemical probe for connecting soluble epoxide hydrolase activity with Nrf2-ARE signaling and osteoclast differentiation. This workflow emphasizes matched vehicle controls, rapid solution use, orthogonal metabolite measurements, and cautious interpretation when target engagement has not yet been confirmed.
-
GSK2606414: A Practical PERK Inhibitor Workflow
2026-08-20
Use GSK2606414 to separate PERK-dependent translational control from broader ER stress and redox responses. This workflow combines selective kinase inhibition with time-resolved Nrf2, viral-stress, cancer, and cell-survival readouts for more defensible mechanism-of-action studies.
-
JC-1 for Mitochondrial Membrane Potential Assays
2026-08-20
JC-1 provides a ratiometric view of mitochondrial polarization, helping distinguish mitochondrial stress from simple changes in cell number or fluorescence intensity. This practical guide translates the dye into reproducible apoptosis detection, mitochondrial dysfunction research, and mechanistic studies of anaplastic thyroid cancer.
-
TAI-1 Hec1 Inhibitor Workflows
2026-08-19
TAI-1 gives cancer researchers a nanomolar tool for connecting Hec1–Nek2 disruption with mitotic errors, apoptosis, and treatment-response phenotypes. This guide combines practical proliferation assays with mechanistic controls and a carefully bounded extension of new findings on transcription–replication conflicts.
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-19
Build reproducible receptor and renal transporter assays with Tropisetron Hydrochloride, from concentration planning to mechanism-aware controls. The workflow connects 5-HT3 receptor pharmacology with OCT2/MATE1 secretion studies while highlighting practical solvent, stability, and interpretation safeguards.
-
CRL3ARMC5 and Integrator Control RNA Pol II
2026-08-18
Cacioppo et al. identify CRL3ARMC5 ubiquitylation and Integrator phosphatase activity as parallel quality-control pathways that regulate RNA polymerase II before productive elongation. The study shows that controlling both polymerase abundance and transcriptional competence is essential for preventing defective complexes from entering gene bodies.
-
Baicalin Reactivates Adult Visual Plasticity
2026-08-18
A 2026 NeuroImage study reports that Baicalin reactivated ocular dominance plasticity and restored visual acuity in adult amblyopic mice when combined with reverse suturing. Imaging, electrophysiology, and pharmacological blockade link this recovery to reduced GABAergic inhibition and perineuronal-net expression in primary visual cortex.
-
Mdivi-1 for Mitochondrial Dynamics Workflows
2026-08-17
Mdivi-1 gives researchers a cell-permeable way to test whether DRP1-driven mitochondrial fission connects extracellular matrix stress with apoptosis and mitochondrial stress signaling. This workflow combines mitochondrial morphology, functional readouts, and disease-relevant validation rather than relying on a single endpoint.
-
T7 RNA Polymerase: From IVT to mRNA Assays
2026-08-17
T7 RNA Polymerase connects precise in vitro transcription with modern mRNA assay design. Learn how template architecture, RNA quality, and the p21-LNP bladder cancer study shape practical decisions for translational RNA research.
-
Protease Inhibitor Cocktail for Lipid Droplet Assays
2026-08-16
Protect DFCP1–ATGL complexes and other labile proteins during starvation, lipid-droplet, and metabolic-stress workflows with a ready-to-dilute 100X formulation. This guide pairs practical extraction parameters with EDTA-aware troubleshooting for Western blotting, Co-IP, imaging, and downstream purification.